Sudhir Agrawal, D. Phil

2014

In 2014, Sudhir Agrawal, D. Phil earned a total compensation of $3M as President of Research at Idera Pharmaceuticals, a 11% increase compared to previous year.

Compensation breakdown

Bonus$285,480
Option Awards$2,153,475
Salary$570,960
Other$32,681
Total$3,042,596

Phil received $2.2M in option awards, accounting for 71% of the total pay in 2014.

Phil also received $285.5K in bonus, $571K in salary and $32.7K in other compensation.

Rankings

In 2014, Sudhir Agrawal, D. Phil's compensation ranked 2,992nd out of 13,032 executives tracked by ExecPay. In other words, Phil earned more than 77.0% of executives.

ClassificationRankingPercentile
All
2,992
out of 13,032
77th
Division
Manufacturing
1,058
out of 4,966
79th
Major group
Chemicals And Allied Products
339
out of 1,686
80th
Industry group
Drugs
264
out of 1,365
81st
Industry
Biological Products, Except Diagnostic Substances
42
out of 236
82nd
Source: SEC filing on April 28, 2017.

Phil's colleagues

We found five more compensation records of executives who worked with Sudhir Agrawal, D. Phil at Idera Pharmaceuticals in 2014.

2014

Vincent Milano

Idera Pharmaceuticals

Chief Executive Officer

2014

Louis Brenner

Idera Pharmaceuticals

Chief Medical Officer

2014

John Wolf

Idera Pharmaceuticals

General Counsel

2014

Louis Arcudi

Idera Pharmaceuticals

Chief Financial Officer

2014

Robert Arbeit

Idera Pharmaceuticals

Former Vice President, Clinical Development

In-depth

You may also like